Core Insights - Innovation Medical's stock price decreased by 2.03% on November 19, trading at 21.24 CNY per share with a total market capitalization of 9.373 billion CNY [1] - The company has seen a significant stock price increase of 166.83% year-to-date, but has experienced declines of 9.50% over the last five trading days, 9.69% over the last twenty days, and 14.49% over the last sixty days [1] - The company has been active in the stock market, appearing on the "Dragon and Tiger List" 19 times this year, with the most recent appearance on October 20, where it recorded a net buy of 242 million CNY [1] Financial Performance - For the period from January to September 2025, Innovation Medical reported a revenue of 597 million CNY, a year-on-year decrease of 2.11%, while the net profit attributable to shareholders was 4.7244 million CNY, reflecting a year-on-year increase of 116.97% [2] - The company has a primary business focus on medical services, which accounts for 99.73% of its revenue, with other income contributing only 0.27% [1] Shareholder Information - As of September 30, the number of shareholders for Innovation Medical reached 130,200, an increase of 58.75% from the previous period, while the average number of circulating shares per shareholder decreased by 37.01% to 3,196 shares [2] Dividend Information - Since its A-share listing, Innovation Medical has distributed a total of 55.8729 million CNY in dividends, with no dividends paid in the last three years [3]
创新医疗跌2.03%,成交额2.96亿元,主力资金净流出2499.27万元